Walmart stock rises even as the retailer says the range of outcomes for first-quarter operating income growth had widened ...

This was the stock's fourth consecutive day of losses.

Bristol Myers Squibb won the dismissal of a proposed class action accusing it of fraudulently obtaining patents and filing ...

Vertex continues to capitalize on its leadership in cystic fibrosis (CF) treatments, where its blockbuster drug Trikafta is ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics ...

Fintel reports that on April 8, 2025, Goldman Sachs downgraded their outlook for Bristol-Myers Squibb (NYSE:BMY) from Buy to ...

Find out how Bristol Myers Squibb was honored for 50 years of service in Lawrence, from local support to global medical ...

Shares of Bristol Myers Squibb Co. BMY shed 3.32% to $55.30 Friday, on what proved to be an all-around grim trading session ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Sell rating on Bristol-Myers Squibb (BMY – Research Report), with a ...

Bristol-Myers Squibb Co. got dismissal of a lawsuit alleging the company used reverse-payment agreements to delay the generic ...

Squibb won the dismissal of a proposed class action accusing it of fraudulently obtaining patents and filing sham patent ...